Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dermatologic therapy

Showing results (111-120 of 4,538) with videos related to

Pageof 454
Sort By:
Dermatologic Therapy|February 23, 2022
Paradoxical Pandora's box of pigmentary side effects by imatinib mesylate in case of chronic myeloid leukemiaSnehal S Pardeshi, Preeti Havanur, Vidya Kharkar, et al.
Dermatologic Therapy|June 2, 2019
Therapeutic options and prognosis of chronic idiopathic erythroderma in older adultsYasunori Ohga, Bolortuya Bayaraa, Shinichi Imafuku
Dermatologic Therapy|June 8, 2019
CLAPO syndrome: Effective response to treatment with oral rapamycinMaría R González-Hermosa, Eneritz Guerra, Iñigo Tuduri, et al.
Dermatologic Therapy|June 8, 2019
The effect of platelet rich plasma on hair regrowth in patients with alopecia areata totalis: A clinical pilot studyFaezeh Khademi, Zohreh Tehranchinia, Fahimeh Abdollahimajd, et al.
Dermatologic Therapy|October 10, 2019
Patterns of response and acquired resistance to the programmed death-1 inhibitor pembrolizumab in Stage III metastatic cutaneous squamous cell carcinomaIris Zalaudek, Paola Corneli, Sibil Vernoni, et al.
Dermatologic Therapy|March 14, 2022
Anti-program cell death receptor-1 induced erythema nodosumCaroline Gerhardt, Kerry Hennessy, Claudia Morr, et al.
Dermatologic Therapy|March 15, 2022
The effect of latanoprost 0.005% solution in the management of scalp alopecia areata, a randomized double-blind placebo-controlled trialMohammadreza Rafati, Reza Mahmoudian, Masoud Golpour, et al.
Dermatologic Therapy|March 15, 2022
Effectiveness of topical pilocarpine in refractory oral lesions of pemphigus vulgaris: Results from an open-label, prospective, pilot studyDipankar De, Anuradha Bishnoi, Shilpa, et al.
Dermatologic Therapy|March 16, 2022
Facial subcutaneous dermatofibrosarcoma protuberans treated with imatinib and monitored with magnetic resonance: A therapeutic alternative for unresectable casesCristian Navarrete-Dechent, Kalee Shah, Shoko Mori, et al.
Dermatologic Therapy|April 8, 2022
Basal cell carcinoma: An updated review of pathogenesis and treatment optionsLoren E Hernandez, Noreen Mohsin, Nicole Levin, et al.
Pageof 454

Showing results (111-120 of 4,538) with videos related to

Sort By:
Pageof 454
Dermatologic Therapy|February 23, 2022
Paradoxical Pandora's box of pigmentary side effects by imatinib mesylate in case of chronic myeloid leukemiaSnehal S Pardeshi, Preeti Havanur, Vidya Kharkar, et al.
Dermatologic Therapy|June 2, 2019
Therapeutic options and prognosis of chronic idiopathic erythroderma in older adultsYasunori Ohga, Bolortuya Bayaraa, Shinichi Imafuku
Dermatologic Therapy|June 8, 2019
CLAPO syndrome: Effective response to treatment with oral rapamycinMaría R González-Hermosa, Eneritz Guerra, Iñigo Tuduri, et al.
Dermatologic Therapy|June 8, 2019
The effect of platelet rich plasma on hair regrowth in patients with alopecia areata totalis: A clinical pilot studyFaezeh Khademi, Zohreh Tehranchinia, Fahimeh Abdollahimajd, et al.
Dermatologic Therapy|October 10, 2019
Patterns of response and acquired resistance to the programmed death-1 inhibitor pembrolizumab in Stage III metastatic cutaneous squamous cell carcinomaIris Zalaudek, Paola Corneli, Sibil Vernoni, et al.
Dermatologic Therapy|March 14, 2022
Anti-program cell death receptor-1 induced erythema nodosumCaroline Gerhardt, Kerry Hennessy, Claudia Morr, et al.
Dermatologic Therapy|March 15, 2022
The effect of latanoprost 0.005% solution in the management of scalp alopecia areata, a randomized double-blind placebo-controlled trialMohammadreza Rafati, Reza Mahmoudian, Masoud Golpour, et al.
Dermatologic Therapy|March 15, 2022
Effectiveness of topical pilocarpine in refractory oral lesions of pemphigus vulgaris: Results from an open-label, prospective, pilot studyDipankar De, Anuradha Bishnoi, Shilpa, et al.
Dermatologic Therapy|March 16, 2022
Facial subcutaneous dermatofibrosarcoma protuberans treated with imatinib and monitored with magnetic resonance: A therapeutic alternative for unresectable casesCristian Navarrete-Dechent, Kalee Shah, Shoko Mori, et al.
Dermatologic Therapy|April 8, 2022
Basal cell carcinoma: An updated review of pathogenesis and treatment optionsLoren E Hernandez, Noreen Mohsin, Nicole Levin, et al.
Pageof 454